Holland Capital invests in Data platform for medical research
Amsterdam/Düsseldorf, 19 December 2023 – Holland Capital invests in German company Honic for further development of their medical data platform.
Using this funding, Honic is able to further roll out its medical data platform. The platform – developed in cooperation with the German privacy regulator and various patient groups – is live since early 2022. The first research projects with universities and international life science companies have already been successfully conducted and completed. In cooperation with renowned partners such as Bundesdruckerei as data handler, IT security company Secunet, and Schwarz Group’s cloud provider StackIT, Honic offers a completely independent solution with its data platform.
Holland Capital led this funding round. Existing investors such as Dieter von Holtzbrinck Ventures, adesso Ventures and Isartal Ventures also participated in this round.
“In recent months, we have shown that the Honic platform is capable of making routinely collected medical data from routine care available for further research. With Holland Capital’s investment, we will further expand the Honic data infrastructure and unlock new data sources to play a pivotal role in the emerging European Health Data Space (EHDS),” said dr. Henrik Matthies, CEO and co-founder of Honic.
“Honic is unique in the European health tech scene as it has been able to develop a data infrastructure aligned with the privacy regulator that can enable large-scale, interdisciplinary medical research. This enables medical research using routinely collected data which is aggregated from different sources . We are delighted to be involved in the next phase of Honic,” said Jan-Frens van Giessel, partner at Holland Capital.
“Holland Capital reinforces Honic’s mission to expand medical science in Germany and Europe. In addition to its financial investment, Holland Capital’s team also supports us with their vast experience and expertise. I am very pleased that we were able to attract international experts such as Harm-Jan Wessels and Achim Plückebaum for the board of Honic,” said Prof. med Jörg F. Debatin, MBA, chairman of the board and co-founder of Honic.
About Honic
Honic was founded by dr. Henrik Matthies and prof. dr. med J. F. Debatin, MBA. The platform, developed in cooperation with the privacy regulator in Germany, uses a unique concept allowing anonymized medical data to be aggregated to generate “Real World” insights for medical research. Since 2022, the platform has been live and successful research projects with universities and international life science companies have been conducted.
About Holland Capital
Over the past 40 years Holland Capital has invested responsibly and successfully in more than 180 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets Healthcare, Technology and Agrifood. The experienced and committed investment team knows what entrepreneurship is all about. It aims for an open, sustainable and professional relationship with the management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Holland Venture invests in semiconductor packaging equipment specialist Boschman Group
Amsterdam/Duiven, March 14th, 2017 – Holland Venture, a Dutch based investment firm, announced today that it completed an investment in the Boschman Group, a specialist in high-end packaging equipment for the semiconductor industry. This investment enables the...
QSight IT strengthens position with InSpark
Inovativ and Sparked are continuing as InSpark Amsterdam, 7 March 2017 – cloud consultancy agencies and Microsoft Gold Partners inovativ and Sparked have joined forces and are continuing as InSpark. InSpark provides a higher level of innovation to customers and...
Holland Venture raises 55 million for a new private equity fund
Amsterdam, 13th of December 2016 - Holland Venture has launched a new private equity fund. The capital is intended for small and medium-sized Dutch companies operating in the fields of Healthcare and Technology. The fundraising went expeditiously; the target amount of...
Holland Venture invests in cloud & security specialist Avensus Netherlands BV
Amsterdam, November 28th, 2016 - Holland Venture invests in cloud and security specialist Avensus. The investment supports Avensus to achieve further growth in the financial and healthcare sector and to further develop its technological expertise in cloud and...
Thanks to investment in Prolira BV, by Holland Venture and Health Innovations, early detection of delirium will be possible.
27 SEPTEMBER 2016: With a cash injection, knowledge and a large network in healthcare, Holland Venture, Health Innovations and two business angels are helping to make Prolira’s Delirium Monitor the new international standard for detection of delirium.Delirium, an...
Holland Venture makes merger Qi ict and Onsight possible: Qsight IT is the largest Dutch player in the field of (cyber) security, networking and cloud.
21st of September 2016 - Holland Venture has played an active role in the merger from Qi ict Delft and Onsight Solutions from Arnhem. The investment contributes to the targeted buy-and-build strategy and confirms its expertise within the Dutch cyber security...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl